Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1988 Nov;56(11):2990–2993. doi: 10.1128/iai.56.11.2990-2993.1988

Adsorbed salivary proline-rich protein 1 and statherin: receptors for type 1 fimbriae of Actinomyces viscosus T14V-J1 on apatitic surfaces.

R J Gibbons 1, D I Hay 1, J O Cisar 1, W B Clark 1
PMCID: PMC259682  PMID: 2902013

Abstract

Use of specific fimbria-defective mutants derived from Actinomyces viscosus T14 has shown that salivary acidic proline-rich protein 1 and statherin serve as receptors for type 1 fimbriae which mediate attachment of the organism to experimental pellicles on apatitic surfaces.

Full text

PDF
2990

Images in this article

2992Image
on p.2992

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennick A., Chau G., Goodlin R., Abrams S., Tustian D., Madapallimattam G. The role of human salivary acidic proline-rich proteins in the formation of acquired dental pellicle in vivo and their fate after adsorption to the human enamel surface. Arch Oral Biol. 1983;28(1):19–27. doi: 10.1016/0003-9969(83)90022-5. [DOI] [PubMed] [Google Scholar]
  2. Cisar J. O., David V. A., Curl S. H., Vatter A. E. Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii. Infect Immun. 1984 Nov;46(2):453–458. doi: 10.1128/iai.46.2.453-458.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cisar J. O., Vatter A. E., Clark W. B., Curl S. H., Hurst-Calderone S., Sandberg A. L. Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae. Infect Immun. 1988 Nov;56(11):2984–2989. doi: 10.1128/iai.56.11.2984-2989.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clark W. B., Wheeler T. T., Cisar J. O. Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae. Infect Immun. 1984 Feb;43(2):497–501. doi: 10.1128/iai.43.2.497-501.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clark W. B., Wheeler T. T., Lane M. D., Cisar J. O. Actinomyces adsorption mediated by type-1 fimbriae. J Dent Res. 1986 Sep;65(9):1166–1168. doi: 10.1177/00220345860650091001. [DOI] [PubMed] [Google Scholar]
  6. Ellen R. P., Banting D. W., Fillery E. D. Longitudinal microbiological investigation of a hospitalized population of older adults with a high root surface caries risk. J Dent Res. 1985 Dec;64(12):1377–1381. doi: 10.1177/00220345850640121001. [DOI] [PubMed] [Google Scholar]
  7. Ellen R. P. Establishment and distribution of Actinomyces viscosus and Actinomyces naeslundii in the human oral cavity. Infect Immun. 1976 Nov;14(5):1119–1124. doi: 10.1128/iai.14.5.1119-1124.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ellen R. P., Segal D. N., Grove D. A. Relative proportions of Actinomyces viscosus and Actinomyces naeslundii in dental plaques collected from single sites. J Dent Res. 1978 Apr;57(4):550–550. doi: 10.1177/00220345780570040201. [DOI] [PubMed] [Google Scholar]
  9. Gibbons R. J., Etherden I. Albumin as a blocking agent in studies of streptococcal adsorption to experimental salivary pellicles. Infect Immun. 1985 Nov;50(2):592–594. doi: 10.1128/iai.50.2.592-594.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gibbons R. J., Etherden I. Enzymatic modification of bacterial receptors on saliva-treated hydroxyapatite surfaces. Infect Immun. 1982 Apr;36(1):52–58. doi: 10.1128/iai.36.1.52-58.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gibbons R. J., Hay D. I. Human salivary acidic proline-rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces. Infect Immun. 1988 Feb;56(2):439–445. doi: 10.1128/iai.56.2.439-445.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hay D. I., Smith D. J., Schluckebier S. K., Moreno E. C. Relationship between concentration of human salivary statherin and inhibition of calcium phosphate precipitation in stimulated human parotid saliva. J Dent Res. 1984 Jun;63(6):857–863. doi: 10.1177/00220345840630060901. [DOI] [PubMed] [Google Scholar]
  13. Hay D. I. The interaction of human parotid salivary proteins with hydroxyapatite. Arch Oral Biol. 1973 Dec;18(12):1517–1529. doi: 10.1016/0003-9969(73)90127-1. [DOI] [PubMed] [Google Scholar]
  14. Kousvelari E. E., Baratz R. S., Burke B., Oppenheim F. G. Immunochemical identification and determination of proline-rich proteins in salivary secretions, enamel pellicle, and glandular tissue specimens. J Dent Res. 1980 Aug;59(8):1430–1438. doi: 10.1177/00220345800590081201. [DOI] [PubMed] [Google Scholar]
  15. Loesche W. J., Syed S. A. Bacteriology of human experimental gingivitis: effect of plaque and gingivitis score. Infect Immun. 1978 Sep;21(3):830–839. doi: 10.1128/iai.21.3.830-839.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Moreno E. C., Kresak M., Hay D. I. Adsorption thermodynamics of acidic proline-rich human salivary proteins onto calcium apatites. J Biol Chem. 1982 Mar 25;257(6):2981–2989. [PubMed] [Google Scholar]
  17. Revis G. J., Vatter A. E., Crowle A. J., Cisar J. O. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence. Infect Immun. 1982 Jun;36(3):1217–1222. doi: 10.1128/iai.36.3.1217-1222.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sandberg A. L., Mudrick L. L., Cisar J. O., Brennan M. J., Mergenhagen S. E., Vatter A. E. Type 2 fimbrial lectin-mediated phagocytosis of oral Actinomyces spp. by polymorphonuclear leukocytes. Infect Immun. 1986 Nov;54(2):472–476. doi: 10.1128/iai.54.2.472-476.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schlesinger D. H., Hay D. I. Complete covalent structure of a proline-rich phosphoprotein, PRP-2, an inhibitor of calcium phosphate crystal growth from human parotid saliva. Int J Pept Protein Res. 1986 Apr;27(4):373–379. doi: 10.1111/j.1399-3011.1986.tb01030.x. [DOI] [PubMed] [Google Scholar]
  20. Schlesinger D. H., Hay D. I. Complete covalent structure of statherin, a tyrosine-rich acidic peptide which inhibits calcium phosphate precipitation from human parotid saliva. J Biol Chem. 1977 Mar 10;252(5):1689–1695. [PubMed] [Google Scholar]
  21. Syed S. A., Loesche W. J. Bacteriology of human experimental gingivitis: effect of plaque age. Infect Immun. 1978 Sep;21(3):821–829. doi: 10.1128/iai.21.3.821-829.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wheeler T. T., Clark W. B. Fibril-mediated adherence of Actinomyces viscosus to saliva-treated hydroxyapatite. Infect Immun. 1980 May;28(2):577–584. doi: 10.1128/iai.28.2.577-584.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wong R. S., Bennick A. The primary structure of a salivary calcium-binding proline-rich phosphoprotein (protein C), a possible precursor of a related salivary protein A. J Biol Chem. 1980 Jun 25;255(12):5943–5948. [PubMed] [Google Scholar]
  24. Wong R. S., Hofmann T., Bennick A. The complete primary structure of a proline-rich phosphoprotein from human saliva. J Biol Chem. 1979 Jun 10;254(11):4800–4808. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES